Results 321 to 330 of about 1,191,834 (353)

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Echocardiography and left ventricular function

Equine Veterinary Journal, 1990
openaire   +2 more sources

Left ventricular wall motion disorders, functional left ventricular aneurysms

The American Journal of Cardiology, 1973
Thomas M. Kazamias, Martin P. Gander
openaire   +1 more source

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

The Lancet, 2003
C. Granger, J. McMurray, S. Yusuf, P. Held, E. Michelson, B. Olofsson, J. Ostergren, M. Pfeffer, K. Swedberg   +8 more
semanticscholar   +1 more source

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

Lancet, The, 2009
Vivek Y Reddy
exaly  

Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease.

New England Journal of Medicine, 1977
J. Borer, S. Bacharach, M. Green, K. Kent, S. Epstein, G. Johnston   +5 more
semanticscholar   +1 more source

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Lancet, The, 2008
Kim Fox, Philippe Gabriel Steg, Michal Tendera   +2 more
exaly  

Left ventricular non-compaction cardiomyopathy

Lancet, The, 2015
Jeffrey A Towbin, Angela Lorts
exaly  

False equivalencies: Online activism from left to right

Science, 2020
Deen Freelon, Alice Marwick
exaly  

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

Lancet, The, 2008
Kim Fox, Philippe Gabriel Steg, Michal Tendera   +2 more
exaly